References
- Wiśniowiecka-Kowalnik B , NowakowskaBA. Genetics and epigenetics of autism spectrum disorder-current evidence in the field. J. Appl. Genet.60(1), 37–47 (2019).
- Aref-Eshghi E , KerkhofJ , PedroVPet al. Evaluation of DNA methylation episignatures for diagnosis and phenotype correlations in 42 Mendelian neurodevelopmental disorders. Am. J. Hum. Genet.106(3), 356–370 (2020).
- American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association, VA, USA (2013).
- Mesleh AG , AbdullaSA , El-AgnafO. Paving the way toward personalized medicine: current advances and challenges in multi-omics approach in autism spectrum disorder for biomarkers discovery and patient stratification. J. Pers. Med.11(1), 41 (2021).
- Sharma SR , GondaX , TaraziFI. Autism spectrum disorder: classification, diagnosis and therapy. Pharmacol. Ther.190, 91–104 (2018).
- Hodges H , FealkoC , SoaresN. Autism spectrum disorder: definition, epidemiology, causes, and clinical evaluation. Transl. Pediatr.9(S1), S55–S65 (2020).
- World Health Organization . Autism spectrum disorders (2021). www.who.int/news-room/fact-sheets/detail/autism-spectrum-disorders
- SFARI gene database . Human gene module (2021). https://gene.sfari.org/database/human-gene/
- Masini E , LoiE , Vega-BenedettiAFet al. An overview of the main genetic, epigenetic and environmental factors involved in autism spectrum disorder focusing on synaptic activity. Int. J. Mol. Sci.21(21), 8290 (2020).
- Wong CC , MeaburnEL , RonaldAet al. Methylomic analysis of monozygotic twins discordant for autism spectrum disorder and related behavioural traits. Mol. Psychiatry19(4), 495–503 (2014).
- Nguyen A , RauchTA , PfeiferGP , HuVW. Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain. FASEB J.24(8), 3036–3051 (2010).
- Andrews SV , SheppardB , WindhamGCet al. Case–control meta-analysis of blood DNA methylation and autism spectrum disorder. Mol. Autism9, 40 (2018).
- Siu MT , ButcherDT , TurinskyALet al. Functional DNA methylation signatures for autism spectrum disorder genomic risk loci: 16p11.2 deletions and CHD8 variants. Clin. Epigenetics11(1), 103 (2019).
- Bend EG , Aref-EshghiE , EvermanDBet al. Gene domain-specific DNA methylation episignatures highlight distinct molecular entities of ADNP syndrome. Clin. Epigenetics11(1), 64 (2019).
- Krzyzewska IM , MaasSM , HennemanPet al. A genome-wide DNA methylation signature for SETD1B-related syndrome. Clin. Epigenetics11(1), 156 (2019).
- Sadikovic B , LevyMA , KerkhofJet al. Clinical epigenomics: genome-wide DNA methylation analysis for the diagnosis of Mendelian disorders. Genet. Med.23(6), 1065–1074 (2021).
- Wong CCY , SmithRG , HannonEet al. Genome-wide DNA methylation profiling identifies convergent molecular signatures associated with idiopathic and syndromic autism in post-mortem human brain tissue. Hum. Mol. Genet.28(13), 2201–2211 (2019).
- Mordaunt CE , JianuJM , LauferBIet al. Cord blood DNA methylome in newborns later diagnosed with autism spectrum disorder reflects early dysregulation of neurodevelopmental and X-linked genes. Genome Med.12(1), 88 (2020).
- Zhu Y , MordauntCE , YasuiDHet al. Placental DNA methylation levels at CYP2E1 and IRS2 are associated with child outcome in a prospective autism study. Hum. Mol. Genet.28(16), 2659–2674 (2019).
- Hannon E , SchendelD , Ladd-AcostaCet al. Elevated polygenic burden for autism is associated with differential DNA methylation at birth. Genome Med.10(1), 19 (2018).